Ranked #1,831 of 8,699 institutional investors
Novo Holdings A/s
Hellerup, G7
$1.49B
US stock portfolio at live prices · today −$10.5M (−0.70%)
Live prices, last trade 11:48 AM ET
- Value at quarter end (Q3 2026)
- $1.49B
- Change from Q2 2026
- −$227.2M (−13.23%)
- Positions
- 25 · 3 new, 0 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$204M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesEWTX 14.6%BN 11.4%COAG 11.2%MIRM 7.40%AVLN 6.53%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| EWTX Edgewise Therapeutics, Inc. | 5,350,000 | $217M | 14.6% | Unchanged |
| BN Brookfield Corporation | 4,465,035 | $170M | 11.4% | Added +28% |
| COAG Hemab Therapeutics Holdings, Inc. | 4,180,550 | $166M | 11.2% | Unchanged |
| MIRM Mirum Pharmaceuticals, Inc. | 1,125,000 | $110M | 7.40% | Unchanged |
| AVLN Avalyn Pharma Inc. | 3,449,191 | $97.1M | 6.53% | Reduced −11% |
| CRM Salesforce, Inc. | 393,187 | $72.5M | 4.87% | Unchanged |
| VRDN Viridian Therapeutics, Inc. | 1,750,000 | $53.8M | 3.62% | Reduced −18% |
| ELVN Enliven Therapeutics, Inc. | 1,000,000 | $46.5M | 3.13% | Unchanged |
| INSM Insmed Incorporated | 284,425 | $41.5M | 2.79% | Added +136% |
| PCVX Vaxcyte, Inc. | 710,000 | $40.2M | 2.70% | Reduced −11% |
| FND Floor & Decor Holdings, Inc. | 797,000 | $38.4M | 2.58% | Unchanged |
| OBX Obsidian Therapeutics, Inc. | 3,123,992 | $37.5M | 2.52% | New |
| FDMT 4D Molecular Therapeutics, Inc. | 3,000,000 | $31.9M | 2.14% | Reduced −8% |
| CLDX Celldex Therapeutics, Inc. | 950,000 | $26.0M | 1.75% | Reduced −7% |
| XENE Xenon Pharmaceuticals Inc. | 652,105 | $24.5M | 1.65% | Added +34% |
| SRRK Scholar Rock Holding Corporation | 460,002 | $23.3M | 1.57% | New |
| DYN Dyne Therapeutics, Inc. | 1,376,164 | $21.7M | 1.46% | Added +43% |
| BABA Alibaba Group Holding Limited | 257,327 | $21.4M | 1.44% | Unchanged |
| MPLT MapLight Therapeutics, Inc. | 2,086,622 | $13.0M | 0.87% | Reduced −43% |
| AVBP ArriVent BioPharma, Inc. | 1,175,000 | $12.9M | 0.87% | Reduced −22% |
| CTNM Contineum Therapeutics, Inc. | 704,013 | $6.2M | 0.42% | New |
| ALMS Alumis Inc. | 1,250,000 | $5.1M | 0.34% | Added +14% |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 2,250,000 | $4.0M | 0.27% | Unchanged |
| MQ Marqeta, Inc. | 110,389 | $1.8M | 0.12% | Unchanged |
| LNZA LanzaTech Global, Inc. | 158,148 | $449K | <0.1% | Unchanged |